CORC

在结果中检索

CORC

浏览/检索结果: 共52条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Observation of large-scale anisotropy in the arrival directions of cosmic rays with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Gao, Wei;  Cao, Qing;  Chen, Songzhan;  Cui, Shuwang;  He, Huihai
收藏  |  浏览/下载：20/0  |  提交时间：2023/01/16
The Crab Nebula: observations and a search for UHE γ-ray flares with LHAASO 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Wang, Lingyu;  Chen, Songzhan;  Cao, Zhen;  He, Huihai;  Wu, Sha
收藏  |  浏览/下载：13/0  |  提交时间：2023/01/16
The performance of the LHAASO-KM2A tested by the cosmic-ray Moon shadow 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Nan, Yuncheng;  Li, Zhe;  Chen, Songzhan;  Feng, Cunfeng;  Wu, Sha
收藏  |  浏览/下载：11/0  |  提交时间：2023/01/16
Detection of emission from Cygnus Cocoon above 100TeV with LHAASO 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Li, Cong;  Chen, Songzhan;  Wu, Sha;  Wang, Lingyu;  Yang, Ruizhi
收藏  |  浏览/下载：12/0  |  提交时间：2023/01/23
Observations of the brightest UHE Gamma-Ray Sources With the LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Wu, Sha;  Chen, SongZhan;  Liu, Ruo-Yu;  Cao, Zhen;  Aharonian, F.
收藏  |  浏览/下载：10/0  |  提交时间：2023/01/23
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Early stage breast cancer screening using an emerging novel liquid biopsy screening technology 会议论文
作者:  Liu, C.;  Dou, J.;  Sheng, Y.;  Wu, J.;  Hu, W.
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
CDA screening technology for multi-ethnic group, early stage breast cancer screening 会议论文
作者:  Tao, H.;  Lin, Y.;  Liu, C.;  Dou, J.;  Sheng, Y.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace